Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
03/1996
03/13/1996EP0700439A1 Lymphocyte chemoattractant factor and uses thereof
03/13/1996EP0700438A1 Opioid receptors: compositions and methods
03/13/1996EP0700436A1 Tumour metastasis gene
03/13/1996EP0700435A1 Transgenic mammals lacking expression of particular cd45 isoforms
03/13/1996EP0700430A1 Methods for selectively stimulating proliferation of t cells
03/13/1996EP0700401A1 Human calcium sensor
03/13/1996EP0700301A1 Peptides and compounds that bind to elam-1
03/13/1996EP0700300A1 Purification of plasma proteins
03/13/1996EP0700295A1 Vitamin b 12? mediated oral delivery systems for gcsf and epo
03/13/1996EP0579607B1 Prescreening of prostate cancer by serum prostatic specific antigen
03/13/1996EP0567562B1 Methods for detecting glucagon antagonists
03/13/1996EP0550691B1 Antibody inductor peptides inhibiting retroviruses of the hiv type and antibodies specific for said peptides
03/13/1996EP0528932B1 Acute pancreatitis associated protein and means for the diagnosis of acute pancreatitis
03/13/1996EP0502962B1 Hirudinmuteins and their polyalkylene glycol conjugates
03/13/1996EP0497929B1 Composition for stabilizing blood plasma during pasteurization
03/13/1996EP0491007B1 Structural alterations of the egf receptor gene in human gliomas
03/13/1996EP0487709B1 Dna probes and primers for detection of b. burgdorferi using the polymerase chain reaction
03/13/1996EP0469036B1 Composition and treatment with biologically active peptides and antibiotic
03/13/1996EP0440772B1 Nucleic acid fragments and diagnostic reagents derived from the hhv6/sie genome and procedures for diagnosing hhv6 infections
03/13/1996EP0438497B1 Vasopermeability-enhancing conjugates
03/13/1996EP0436545B1 Therapeutic methods using catalytic antibodies
03/13/1996EP0428602B1 Polypeptides and dna encoding same
03/13/1996EP0427863B1 Dna coding for protein capable of combining with enhancer of alpha-fetoprotein gene
03/13/1996EP0401384B1 Chemically modified granulocyte colony stimulating factor
03/13/1996CN1118601A Inhibitors of herpes viral ribonucleotide reductase
03/13/1996CN1118573A Peptides for inducing cytotoxic T lymphocyte responses to hepatitis B virus
03/13/1996CN1031267C Compounds for anti-dementia medicine and its usage
03/13/1996CN1031242C 化妆品组合物 Cosmetic composition
03/13/1996CA2157851A1 Insulin analog formulations
03/12/1996US5498728 Osteoporosis
03/12/1996US5498698 Megakaryocyte potentiator
03/12/1996US5498697 Protein possessing metastasis-inhibitory activity
03/12/1996US5498696 Sterol regulatory element binding proteins and their use in screening assays
03/12/1996US5498694 Antibodies for immunology
03/12/1996US5498601 Rgd sequence
03/12/1996US5498600 Platelet derived growth factor, wound healing
03/12/1996US5498599 Methods for stimulating platelet production
03/12/1996US5498597 FKBP-13, an FK506-binding immunophilin
03/12/1996US5498538 Totally synthetic affinity reagents
03/12/1996US5498533 Control of growth and development of potato plants
03/12/1996US5498529 Genetic engineering
03/12/1996US5498521 Diagnosis of hereditary retinal degenerative diseases
03/12/1996US5498499 Peptides and antibodies that inhibit platelet adhesion
03/12/1996US5498413 Recombinant subunit vaccine against porcine parvovirus
03/12/1996CA2053317C Active carbonates of polyalkylene oxides for modification of polypeptides
03/12/1996CA1338163C Process for the preparation of n-alkylated dipeptides and their esters
03/12/1996CA1338162C Process for the preparation of n-alkylated dipeptides and their esters
03/11/1996CA2157980A1 Allergenic peptides from cryptomeria japonica and their uses
03/10/1996CA2157811A1 Biotinylated latex microsphere; process for preparing the same and use thereof as a biological detector
03/07/1996WO1996006943A1 Cell cycle regulated repressor and dna element
03/07/1996WO1996006942A1 Genetically altered t-cells
03/07/1996WO1996006940A1 Genetic therapy of tumours with an endothelium cell-specific active substance which is dependent on the cell cycle
03/07/1996WO1996006939A1 Genetic therapy of diseases of the central nervous system with a cell-specific active substance which is dependent on the cell cycle
03/07/1996WO1996006938A1 Genetic therapy of vascular diseases with a cell-specific active substance which is dependent on the cell cycle
03/07/1996WO1996006937A1 Improvements in production of proteins in host cells
03/07/1996WO1996006934A1 Infectious peritonitis vaccine
03/07/1996WO1996006933A1 Gene therapy for transplantation and inflammatory or thrombotic conditions
03/07/1996WO1996006927A1 Transgenic animal expressing a familial form of human amyloid precursor protein
03/07/1996WO1996006863A1 Agents for inducing apoptosis and applications of said agents in therapy
03/07/1996WO1996006862A1 Gabaa receptor epsilon subunit
03/07/1996WO1996006861A1 Trefoil peptide dimer
03/07/1996WO1996006860A2 Gradual modification, super-agonists and antagonists of signal-proteins and peptides
03/07/1996WO1996006859A1 Trophic factors for central nervous system regeneration
03/07/1996WO1996006858A1 (1→3)-β-D-GLUCAN-BINDING PROTEIN, ANTIBODY THAT RECOGNIZES THE PROTEIN, AND USE OF THE PROTEIN AND ANTIBODY
03/07/1996WO1996006856A1 Dopamine receptor peptides and anti-peptide antibodies
03/07/1996WO1996006642A1 Allogeneic and xenogeneic transplantation
03/07/1996WO1996006641A1 Conjugates of vascular endothelial growth factor with targeted agents
03/07/1996WO1996006638A1 Method for enhancing immunogenicity, product obtained and pharmaceutical composition
03/07/1996WO1996006632A1 Compositions and methods for delivery of polypeptides
03/07/1996WO1996006630A1 Methods and compositions for modulating a t cell response
03/07/1996WO1996006629A1 HIGH-AFFINITY RESPONSE-SELECTIVE C-TERMINAL ANALOGS OF C5a ANAPHYLATOXIN
03/07/1996WO1996006628A1 Biologically active fragments of glucagon-like insulinotropic peptide
03/07/1996WO1996006627A1 Mutant enterotoxin effective as a non-toxic oral adjuvant
03/07/1996WO1996006626A1 Analgesic method with dynorphin analogues truncated at the n-terminus
03/07/1996WO1996006624A1 A mutant protein and methods and materials for making and using it
03/07/1996WO1996006619A1 Polynucleic acids and proteins from a porcine reproductive and respiratory syndrome virus and uses thereof
03/07/1996WO1996004393A3 Control of plant gene expression
03/07/1996WO1996004385A3 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use
03/07/1996WO1996003515A3 Surface expression of enzyme in gene directed prodrug therapy
03/07/1996WO1996003509A3 Insect viruses, sequences, insecticidal compositions and methods of use
03/07/1996WO1996003506A3 Analog of haemophilus hin47 with reduced protease activity
03/07/1996WO1996002641A3 Materials and methods relating to the diagnosis and prophylactic and therapeutic treatment of synovial sarcoma
03/07/1996WO1995032430A3 Assay for pathogenicity of anti-dna antibodies
03/07/1996WO1995032291A3 Hepatitis g virus and molecular cloning thereof
03/07/1996WO1995022561A3 Peptides recognized by melanoma-specific cytotoxic lymphocytes, and uses therefor
03/07/1996DE4431297A1 Antibody VFF-18 specific for epitope encoded by exon v6 of CD44
03/07/1996DE19532001A1 New antibacterial peptide, moricin, from silkworms
03/07/1996DE19531931A1 Modulatoren des Körpergewichts, korrespondierende Nukleinsäuren und Proteine, und diagnostische und therapeutische Verwendungen derselben Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
03/07/1996CA2199005A1 Compositions and methods for delivery of polypeptides
03/07/1996CA2198940A1 Methods and compositions for modulating a t cell response
03/07/1996CA2198919A1 Gradual modification, super agonists and antagonists of signs and peptides
03/07/1996CA2198587A1 Trophic factors for central nervous system regeneration
03/07/1996CA2198479A1 Method for enhancing immunogenicity, product obtained and pharmaceutical composition
03/07/1996CA2198474A1 Genetic therapy of diseases of the central nervous system with a cell-specific active substance which is dependent on the cell cycle
03/07/1996CA2198473A1 Gene therapy of tumors with an endothelial cell-specific, cell cycle-dependent active compound
03/07/1996CA2198472A1 Genetic therapy of vascular diseases with a cell-specific active substance which is dependent on the cell cycle
03/07/1996CA2198451A1 Transgenic animal expressing a familial form of human amyloid precursor protein
03/07/1996CA2198348A1 Analgesic method with dynorphin analogues truncated at the n-terminus
03/07/1996CA2198345A1 Improvements in production of proteins in host cells
03/07/1996CA2198080A1 Cell cycle regulated repressor and dna element
1 ... 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 2569 2570 2571 2572 2573 2574 2575 ... 2916